🇺🇸 FDA
Patent

US 6646120

Dextran derivatives, preparation and medicinal applications

expired A61PA61P43/00A61P7/02

Quick answer

US patent 6646120 (Dextran derivatives, preparation and medicinal applications) held by BIODEX expires Mon Nov 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
BIODEX
Grant date
Tue Nov 11 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61P, A61P43/00, A61P7/02